N@N

ATVI, FLEX, BRCM, DSCO, ONNN, AMLN With Highest Daily Short Volume On NASDAQ Tuesday

^{Published on 2009-09-29 15:15:06, Last Modified on 2010-12-22 14:49:36 - WOPRAI}
 

September 30, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, has reviewed the NASDAQ Daily Short Volume Report for Tuesday, September 28th, 2009 and come to the following statistical conclusions. There were 6,721 stocks with daily short volume reported and total NASDAQ trading volume of 1,573,430,199 shares. Total Daily Short Volume was 782,944,531 shares. 49.76% of all trading on the NASDAQ Tuesday was short selling. The chart below highlights 6 stocks that had the highest daily short volume yesterday. Activision Blizzard (NASDAQ: ATVI), Flextronics (NASDAQ: FLEX), Broadcom (NASDAQ: BRCM), Discovery Laboratories (NASDAQ: DSCO), ON Semiconductor (NASDAQ: ONNN), Amylin Pharmaceuticals (NASDAQ: AMLN). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.

DATE SYMBOL SHORT VOLUME TOTAL VOLUME MARKET PERCENT

20090929 ATVI 3,304,784 5,402,593 Q 61.17%

20090929 FLEX 2,491,089 4,869,240 Q 51.16%

20090929 BRCM 1,967,143 4,111,693 Q 47.84%

20090929 DSCO 1,411,652 3,947,611 Q 35.76%

20090929 ONNN 1,321,802 2,362,501 Q 55.95%

20090929 AMLN 1,032,589 1,903,872 Q 54.24%

In late October 2008 the SEC updated Regulation SHO requiring that all short sellers must locate, borrow and deliver any shares they have shorted, no exceptions, by T+3 settlement date. If not, a buy-in must be forced by the broker dealer that the short seller transacted through by the opening of the market on T+4. Since a company first appears on the naked short list when short sellers have been failing to deliver for 5 consecutive trading days, stocks should theoretically never be on the naked short list again. BUYINS.NET will monitor the exchangesai naked short lists daily and issue an alert and notify the SEC and FINRA should short sellers fail to deliver on any short sales.

Reg SHO Rule 204 (i) requires brokers to deliver shares on long and short sales of publicly traded equity securities by settlement date, (ii) continues to require brokers to close-out fails to deliver by the beginning of trading on T+4 for short sales and T+6 for long sales, (iii) precludes clearing brokers and their introducing brokers from selling short a security, other than on a pre-borrowed basis, if a fail to deliver in that security is not timely closed out until the fail is closed out and that close-out transaction settles, (iv) allows clearing brokers to allocate fails to introducing brokers and (v) continues to permit brokers to rely upon pre-fail credit to satisfy Rule 204's close-out requirement to avoid the pre-borrow requirements when a fail at a clearing broker has not been closed out. However, the SEC liberalized certain of these provisions in several regards. For example, permanent Rule 204 now allows a broker to close-out a fail on a long sale by borrowing the security, whereas Rule 204T had only permitted closing out long fails by buying-in, which should alleviate some of the buy-in risk for investors that experience long fails. Similar relief was extended to close-outs for market maker fails, so that a fail from a bona fide market making transaction (including short and long fails) can now be closed out by the beginning of trading on T+6 by borrowing the security. Further, Rule 204 now permits a broker to borrow securities to obtain pre-fail credit for early close-outs, whereas temporary Rule 204T only permitted pre-fail credit to be obtained by purchases of securities.

The SEC refused requests to extend the close-out deadline for fails to deliver to the close of business on the close-out deadline, choosing instead to retain the requirement that all fails be closed out by the beginning of trading on the applicable close-out deadline. The Commission also rejected requests for a fail to deliver exception that would have provided an exception from the close-out requirements if a clearing broker's fail position was below a certain amount but said that it would continue to monitor whether a de minimis or odd lot exception could be warranted.

Activision Blizzard, Inc. (NASDAQ: ATVI), through its subsidiaries, publishes online, personal computer (PC), console, and hand-held games worldwide. The company develops and publishes video games, as well as maintains its proprietary online-game related service, Battle.net. It also publishes interactive software products and peripherals internationally. The companyais products cover various game categories, including action/adventure, action sports, racing, role-playing, simulation, first-person action, music, and strategy. Its products include Guitar Hero, Call of Duty, Tony Hawk, Spider-Man, X-Men, James Bond, and Transformers, as well as Diablo, StarCraft, Warcraft, and World of Warcraft. The company is based in Santa Monica, California. Activision Blizzard, Inc. is a subsidiary of Vivendi S.A.

Flextronics International Ltd. (NASDAQ: FLEX) provides vertically-integrated advanced design and electronics manufacturing services to original equipment manufacturers of a range of products in infrastructure, mobile communication devices, computing, consumer digital devices, industrial, semiconductor, white goods, automotive, marine, aerospace, and medical devices markets. The companyais services include printed circuit board (PCB) and flexible circuit fabrication; systems assembly and manufacturing, such as enclosures, testing services, and materials procurement and inventory management; and design and engineering services comprise interface and industrial design, mechanical engineering and tooling design, electronic system design, and PCB design. It also offers original design manufacturing services; components design and manufacturing for display solutions, optomechatronics, and power supplies, as well as thin film transistor display modules for mobile phones, industrial and commercial cameras, MP3 players, and digital cameras; and reverse logistics and repair services. In addition, the company provides forward logistics solutions, including supplier managed inventory, inbound freight management, build/configure to order, order fulfillment and distribution, supply chain network design, and collaborative control tower; and after-sales services, such as product repair, re-manufacturing, and maintenance. Its services help its customers in Asia, the Americas, and Europe to design, build, ship, and service electronics products. Flextronics International Ltd. was founded in 1990 and is based in Singapore, Singapore.

Broadcom Corporation (NASDAQ: BRCM) engages in the design, development, and supply of semiconductors for wired and wireless communications equipment manufacturers. The companyais products enable the delivery of voice, video, data, and multimedia to and throughout the home, office, and mobile environment. It provides a portfolio of system-on-a-chip and software solutions to manufacturers of computing and networking equipment, digital entertainment and broadband access products, and mobile devices. The company offers solutions for digital cables, satellite and Internet protocol set-top boxes, and media servers; high definition televisions; high definition DVD players and personal video recording devices; cable and digital subscriber line modems and residential gateways; high-speed transmission and switching for local, metropolitan, wide area, and storage networking; and server solutions. It also provides its solutions for broadband network and security processors; wireless and personal area networking; cellular communications; global positioning system applications; mobile multimedia and applications processors; mobile power management; and voice over Internet protocol gateway and telephony systems. The company markets its products in the United States through direct sales force, distributors, and manufacturersai representatives. Broadcom Corporation also sells its products internationally through regional offices, as well as through a network of independent distributors and representatives in Asia, Australia, Europe, and North America. The company was founded in 1991 and is headquartered in Irvine, California.

Discovery Laboratories, Inc. (NASDAQ: DSCO), a biotechnology company, engages in developing surfactant replacement therapies (SRT) to treat respiratory disorders and diseases. The companyais proprietary technology, KL4 Surfactant Technology, produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant. Its products include Surfaxin, a synthetic, peptide-containing surfactant for use in pediatric medicine; Surfaxin (lucinactant) for the prevention of respiratory distress syndrome (RDS) in premature infants; and Aerosurf, which is a KL4 Surfactant in aerosolized form to treat premature infants at risk for RDS. Discovery Laboratories also focuses on the development of Surfaxin to address bronchopulmonary dysplasia in premature infants, acute respiratory failure in children, cystic fibrosis, acute lung injury, and other diseases associated with the inflammation of the lung, such as asthma and chronic obstructive pulmonary disease. The company has a license agreement with Philip Morris USA Inc. to use its Capillary Aerosolization Technology for use with pulmonary surfactants for the respiratory diseases; and has a strategic alliance with Laboratorios del Dr. Esteve, S.A. to develop, market, and sell surfactant products in Andorra, Greece, Italy, Portugal, and Spain. Discovery Laboratories was founded in 1992 and is headquartered in Warrington, Pennsylvania.

ON Semiconductor Corporation (NASDAQ: ONNN) offers power, analog, digital signal processing, mixed signal, logic, data management semiconductors, memory, and standard component devices worldwide. The company designs, manufactures, and markets a portfolio of semiconductor components that address the design needs of electronic systems and products. Its power management semiconductor components are used to control, convert, protect, and monitor the supply of power to different elements within various electronic devices; and data management semiconductor components provide clock management and data flow management for precision computing and communications systems. Its Automotive and Power Regulation segment offers amplifiers, comparators, voltage regulators, and references; AC-DC/DC-DC converters; ignition insulated gate bipolar transistors; and high voltage MOS field effect transistors used in power conditioning and switching applications. The companyais Computing Products segment provides controllers and power MOSFETs for power management in VCORE, DDR, and chipsets. Its Digital and Consumer Products segment offers products for digital portable devices in four application areas, such as system power management with FETs and DC-DC converters; EMI and RF filtering; audio and video signal distribution with analog switches and op amps; and LED lighting solutions for LCD screens and camera flash. The companyais Standard Products segment provides standard diode and transistor products, over-voltage protection products, standard logic products, and high frequency products for consumer electronics, computing, wireless communications, industrial electronics, and networking markets. Its Custom And Foundry Product Group segment engages in the design and manufacture of customer-specific and standard semiconductor products for the automotive, medical, industrial, communications, and military, and aerospace markets. The company was founded in 1999 and is headquartered in Phoenix, Arizona.

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN), a biopharmaceutical company, focuses on improving the lives of people with diabetes, obesity, and other diseases through the discovery, development, and commercialization of innovative medicines. The company has developed and gained approval for two medicines for diabetes, SYMLIN (pramlintide acetate) injection and BYETTA (exenatide) injection. The company also has research and development (R&D) programs in the therapeutic areas of diabetes and obesity. Its R&D programs for diabetes include exenatide once weekly, exenatide once weekly pen, exenatide suspension formulation, exenatide nasal, and the exenatide transdermal patch. The companyais R&D programs for obesity comprise pramlintide/metreleptin combination therapy and davalintide. Amylin Pharmaceuticals markets its products to healthcare providers, managed healthcare organizations, wholesalers and pharmacies, government purchasers, and other third-party payers primarily in the United States. It partners with Eli Lilly and Company for the development of exenatide; Alkermes, Inc. for the development of potential long-acting formulations of exenatide; and Biocon Limited to develop, commercialize, and manufacture a novel peptide therapeutic for the treatment of diabetes. Amylin Pharmaceuticals was founded in 1987 and is based in San Diego, California.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each monthais short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies or third parties pay $995 per month to purchase data for information provided in monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net